News
Faster, cheaper, better: the rise of blood tests for Alzheimer’s
NGP Faculty, Robert Rissman, is asked about how circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.

Click Here for the Full Article (Source: Nature)